These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38976273)

  • 1. Perinatal Outcomes After RSV Vaccination During Pregnancy-Addressing Emerging Concerns.
    Regan AK
    JAMA Netw Open; 2024 Jul; 7(7):e2419229. PubMed ID: 38976273
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonadjuvanted Bivalent Respiratory Syncytial Virus Vaccination and Perinatal Outcomes.
    Son M; Riley LE; Staniczenko AP; Cron J; Yen S; Thomas C; Sholle E; Osborne LM; Lipkind HS
    JAMA Netw Open; 2024 Jul; 7(7):e2419268. PubMed ID: 38976271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnant women and older adults in England and Scotland to be offered RSV vaccination.
    Mahase E
    BMJ; 2024 Jun; 385():q1436. PubMed ID: 38936955
    [No Abstract]   [Full Text] [Related]  

  • 4. Informing randomized clinical trials of respiratory syncytial virus vaccination during pregnancy to prevent recurrent childhood wheezing: A sample size analysis.
    Riddell CA; Bhat N; Bont LJ; Dupont WD; Feikin DR; Fell DB; Gebretsadik T; Hartert TV; Hutcheon JA; Karron RA; Nair H; Reiner RC; Shi T; Sly PD; Stein RT; Wu P; Zar HJ; Ortiz JR;
    Vaccine; 2018 Dec; 36(52):8100-8109. PubMed ID: 30473186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety Concerns Put a Stop to Maternal RSV Vaccine Study.
    Harris E
    JAMA; 2024 May; 331(17):1439. PubMed ID: 38607635
    [No Abstract]   [Full Text] [Related]  

  • 6. Maternal awareness, acceptability and willingness towards respiratory syncytial virus (RSV) vaccination during pregnancy in Ireland.
    McCormack S; Thompson C; Nolan M; Imcha M; Dee A; Saunders J; Philip RK
    Immun Inflamm Dis; 2024 Apr; 12(4):e1257. PubMed ID: 38661110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnant women's knowledge and attitude to maternal vaccination including group B streptococcus and respiratory syncytial virus vaccines.
    Giles ML; Buttery J; Davey MA; Wallace E
    Vaccine; 2019 Oct; 37(44):6743-6749. PubMed ID: 31540809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes of Pregnant Women and Healthcare Professionals Toward Clinical Trials and Routine Implementation of Antenatal Vaccination Against Respiratory Syncytial Virus: A Multicenter Questionnaire Study.
    Wilcox CR; Calvert A; Metz J; Kilich E; MacLeod R; Beadon K; Heath PT; Khalil A; Finn A; Snape MD; Vandrevala T; Nadarzynski T; Coleman MA; Jones CE
    Pediatr Infect Dis J; 2019 Sep; 38(9):944-951. PubMed ID: 31261362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy?
    Munoz FM
    Curr Opin Infect Dis; 2015 Jun; 28(3):221-4. PubMed ID: 25918956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants.
    Madhi SA; Polack FP; Piedra PA; Munoz FM; Trenholme AA; Simões EAF; Swamy GK; Agrawal S; Ahmed K; August A; Baqui AH; Calvert A; Chen J; Cho I; Cotton MF; Cutland CL; Englund JA; Fix A; Gonik B; Hammitt L; Heath PT; de Jesus JN; Jones CE; Khalil A; Kimberlin DW; Libster R; Llapur CJ; Lucero M; Pérez Marc G; Marshall HS; Masenya MS; Martinón-Torres F; Meece JK; Nolan TM; Osman A; Perrett KP; Plested JS; Richmond PC; Snape MD; Shakib JH; Shinde V; Stoney T; Thomas DN; Tita AT; Varner MW; Vatish M; Vrbicky K; Wen J; Zaman K; Zar HJ; Glenn GM; Fries LF;
    N Engl J Med; 2020 Jul; 383(5):426-439. PubMed ID: 32726529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RSV Vaccination Intention Among People Who Are or Plan to Become Pregnant.
    Saper JK; Heffernan M; Simon NE; Davis MM; Macy ML
    Pediatrics; 2024 May; 153(5):. PubMed ID: 38660734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive and active immunization against respiratory syncytial virus for the young and old.
    Villafana T; Falloon J; Griffin MP; Zhu Q; Esser MT
    Expert Rev Vaccines; 2017 Jul; 16(7):1-13. PubMed ID: 28525961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the Effects of Active Immunisation against Respiratory Syncytial Virus (RSV) using Decision-Analytic Models: A Systematic Review with a Focus on Vaccination Strategies, Modelling Methods and Input Data.
    Treskova M; Pozo-Martin F; Scholz S; Schönfeld V; Wichmann O; Harder T
    Pharmacoeconomics; 2021 Mar; 39(3):287-315. PubMed ID: 33462760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ethics framework and practical guidance for post-trial access to an RSV maternal vaccine.
    Mazur NI; Bont LJ; van Delden JJM; Omer SB
    Lancet Respir Med; 2019 Jun; 7(6):474-476. PubMed ID: 31003966
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPreF3) in Mothers and Their Infants: A Phase 2 Randomized Trial.
    Bebia Z; Reyes O; Jeanfreau R; Kantele A; De Leon RG; Sánchez MG; Banooni P; Gardener GJ; Rasero JLB; Pardilla MBE; Langley JM; Di Leo CM; Botelho-Nevers E; Buttery J; Laurichesse H; Madhi SA; García AM; Stanley T; Barjat T; Griffith R; Castrejón-Alba MM; de Heusch M; Dieussaert I; Hercor M; Lese P; Qian H; Tullio AN; Henry O
    J Infect Dis; 2023 Aug; 228(3):299-310. PubMed ID: 36722147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Priorities for developing respiratory syncytial virus vaccines in different target populations.
    Drysdale SB; Barr RS; Rollier CS; Green CA; Pollard AJ; Sande CJ
    Sci Transl Med; 2020 Mar; 12(535):. PubMed ID: 32188721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential impact of maternal vaccination on life-threatening respiratory syncytial virus infection during infancy.
    Scheltema NM; Kavelaars XM; Thorburn K; Hennus MP; van Woensel JB; van der Ent CK; Borghans JAM; Bont LJ; Drylewicz J
    Vaccine; 2018 Jul; 36(31):4693-4700. PubMed ID: 29941327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory Syncytial Virus Maternal Vaccination in Infants below 6 Months of Age: Meta-Analysis of Safety, Immunogenicity, and Efficacy.
    Mapindra MP; Mahindra MP; McNamara P; Semple MG; Clark H; Madsen J
    Neonatology; 2024; 121(3):271-282. PubMed ID: 38286126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in Maximizing Impacts of Preventive Strategies against Respiratory Syncytial Virus (RSV) Disease in Young Children.
    Zheng Z
    Yale J Biol Med; 2022 Jun; 95(2):293-300. PubMed ID: 35782467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age.
    August A; Glenn GM; Kpamegan E; Hickman SP; Jani D; Lu H; Thomas DN; Wen J; Piedra PA; Fries LF
    Vaccine; 2017 Jun; 35(30):3749-3759. PubMed ID: 28579233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.